Logo image
Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne bla IMP-1 in a Tertiary Hospital
Journal article   Peer reviewed

Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne bla IMP-1 in a Tertiary Hospital

Ana Carolina Ramos, Rodrigo Cayô, Cecilia Godoy Carvalhaes, Thomas Jové, Greice Pereira da Silva, Fernanda Maciel Paschoin Sancho, Thomas Chagas-Neto, Eduardo Alexandrino Servolo Medeiros and Ana Cristina Gales
Antimicrobial agents and chemotherapy, Vol.62(2), e01321-17
02/2018
DOI: 10.1128/AAC.01321-17
PMID: 29158274

View Online

Abstract

This study aimed to characterize multidrug-resistant clones carrying a novel class 1 integron-borne In was inserted into a large conjugative plasmid that also carried The production of carbapenemases in that are intrinsically resistant to polymyxins and tigecycline is very worrisome, representing a serious challenge to clinicians and infection control teams.
Anti-Bacterial Agents - pharmacology beta-Lactamases - genetics beta-Lactamases - metabolism Brazil - epidemiology Carbapenems - pharmacology Clone Cells Drug Resistance, Multiple, Bacterial - genetics Gene Expression Regulation, Bacterial Humans Integrons Microbial Sensitivity Tests Plasmids - chemistry Plasmids - metabolism Polymyxins - pharmacology Proteus Infections - drug therapy Proteus Infections - epidemiology Proteus Infections - microbiology Proteus Infections - transmission Proteus mirabilis - drug effects Proteus mirabilis - enzymology Proteus mirabilis - genetics Proteus mirabilis - isolation & purification Tertiary Care Centers Tigecycline - pharmacology

Details

Logo image